Advertisement

Acta Neuropathologica

, Volume 34, Issue 3, pp 199–206 | Cite as

Damage of skeletal muscle in rats by immunoglobulins

I. Pathophysiological data and lightmicroscopic observations
  • A. Korényi-Both
  • Gabriella Kelemen
Original Investigations

Summary

An experimental model of the autoimmune process was developed to study the pathophysiological and structural changes in immunomyopathies. Immune-sera derived from three muscle proteins—myofibril, myosin and actin—produced immunomyopathies for study. The pathophysiological data show that the general muscle efficiency began to decrease with the early stages of treatment and reflected a severe disorder to muscle function with the progression of time. Parallel changes were also observed by light microscopy.

Key words

Immunomyopathy Muscle disease Experimental muscle pathology Pathophysiology Morphology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature

  1. Arnason, B., Samaha, F. J.: Studies in progress on the stimulation of myasthenia gravis like states in experimental animals by immunologic means. Paper read at NIH meeting on experimental models of myasthenia gravis, Bethesda (1967)Google Scholar
  2. Bárány, M., Biró, N. A., Molnár, J., Straub, F. B.: Darstellung enzymfreien Actins durch Umfallung mit Magnesium. Acta physiol. Acad. Sci. hung.5, 369–381 (1954)Google Scholar
  3. Dawkins, R. L.: Experimental myositis associated with hypersensitivity to muscle. J. Path. Bact.90, 618–625 (1965)Google Scholar
  4. Douglas, S. D., Gottlieb, A. J., Strauss, A. J. L., Spicer, S. S.: Electron microscopic localization of striated muscle binding factor in myasthenia gravis by ferritin labeled antibody. Fed. Proc.24, 370 (Abstr. 1335) (1965)Google Scholar
  5. Frenkl, R., Csalay, L.: The effect of regular muscle activity on the function of adrenal cortex in rats (in Hung.). Kisérl. Orvostud.14, 473–478 (1962)Google Scholar
  6. Gornall, A. G., Bardawill, C. J., David, M. M.: Determination of serum proteins by means of the biuret reaction. J. biol. Chem.177, 751–766 (1949)Google Scholar
  7. Goldstein, G., Whittingham, S.: Experimental auto-immune thymitis. An animal model of human myasthenia gravis. Lancet1966 II, 315–318Google Scholar
  8. Gottlieb, A. J., Douglas, S. D., Strauss, A. J. L., Spicer, S.: Ultrastructural localization of gamma-globulin binding to skeletal muscle. Ann. N. Y. Acad. Sci.135, 638–643 (1966)Google Scholar
  9. Grob, D., Namba, T., Sato, T., Klein, D. R.: Effect on skeletal muscle of serum of myasthenic patients and of rabbits immunized with muscle constituents. Fed. Proc.24, 693 (1965)Google Scholar
  10. Kakulas, B. A.: Destruction of differentiated muscle cultures. J. Path. Bact.91, 495–503 (1955)Google Scholar
  11. Kawanami, S., Mori, R.: Experimental myasthenia in mice (The role of the thymus and lymphoid cells). Clin. exp. Immunol.12, 447–454 (1972)Google Scholar
  12. Knoll, J.: Pharmacology (in Hung.). Med. Konyvkiado218 (1965)Google Scholar
  13. Masugi, M.: Über die experimentelle Glomerulonephritis durch das spezifische Antinierenserum. Beitr. path. Anat.92, 429–467 (1934)Google Scholar
  14. McFarlin, E. D., Johnson, J. S., Seymour, W. F. K.: Antimuscle factor and antinuclear factor in patient with myasthenia gravis. J. Immunol.101, 104–110 (1968)Google Scholar
  15. Mendell, J. R., Whitaker, J. N., Engel, W. K.: The skeletal muscle binding site of antistriated muscle antibody in myasthenia gravis; an electron microscopic immunohistochemical study using peroxidase conjugated antibody fragment. J. Immunol.111, 847–856 (1973)Google Scholar
  16. Miescher, P. A., Muller-Eberhard, H. I.: Testbook of immunopathology. New York-London: Grune and Stratton 1969Google Scholar
  17. Mommaerts, W. F. H. M.: Reversible polymerization and ultracentrifugal purification of actin. J. biol. Chem.188, 559–565 (1951)Google Scholar
  18. Nastuk, W. L., Kessley, H. J., Grynbaum, A., Smith, M., Herman, C., Jr.: Immunological changes following thymectomy in myasthenia gravis. Arch. Neurol. (Chic.)15, 1–12 (1966)Google Scholar
  19. Oudin, J.: The genetic control of immunoglobulin synthesis. Proc. roy. Soc. B166, 207–221 (1966)Google Scholar
  20. Pepe, F. A.: Some aspects of the structural organization of the myofibril as revealed by antibody staining methods. J. Cell Biol.28, 505–525 (1966)Google Scholar
  21. Perry, S. V.: The bound nucleotide of the isolated myofibril. Biochem. J.51, 495–499 (1952)Google Scholar
  22. Portzehl, H., Schramm, G., Weber, H. H.: Actomyosin und seine Komponenten. I. Mitt. Z. Naturforsch.5, 61–69 (1950)Google Scholar
  23. Rook, H., Wilkinson, D. S., Ebling, F. J. G.: Textbook of Dermatology, 3rd ed. (1967)Google Scholar
  24. Sagan, Z.: The application of rivanol for serum transferrin and immunoglobulin G. determination. Clin. chim. Acta21, 225–230 (1968)Google Scholar
  25. Strauss, A. J. L., Deitch, A., Hsu, K.: Further observations on the localization of a muscle binding, complement fixing serum globulin fraction in myasthenia gravis. Fed. Proc.20, 38 (1961)Google Scholar
  26. Strauss, A. J. L., Kemp, P. G., Douglas, S. D.: Myasthenia gravis. Lancet1966I, 772–773Google Scholar
  27. Strauss, A. J. L., Kemp, P. G., Jr.: Serum autoantibodies in myasthenia gravis and thymoma, selective affinity for I-bands of striated muscle as a guide to identification of antigen. J. Immunol.99, 945–953 (1967)Google Scholar
  28. Strauss, A. J. L., Smith, C. W., Case, G. W., van der Geld, H. W. R., McFarlin, D. E., Barlow, M.: Further studies on the specificity of presumed immuno associations of myasthenia gravis and consideration of possible pathogenic implications. Ann. N. Y. Acad. Sci.135, 557–579 (1966)Google Scholar
  29. Tal, C., Liban, E.: Experimental production of muscular dystrophy-like lesions in rabbits and guinea-pigs by an auto-immune process. Brit. J. exp. Path.43, 525–529 (1962)Google Scholar
  30. Tolnai, G.: Muscle lesions in mice injected with isologous and homologous muscle extracts. Nature (Lond.)212, 1429–1431 (1966)Google Scholar
  31. Van Der Geld, H., Feltkamp, T. E., Van Loghem, J. J., Oosterhuis, H. J. G. H.: Reactivity of myasthenia gravis serum gammaglobulin with skeletal muscle and thymus demonstrated by immunofluorescence. Proc. Soc. exp. Biol. (N. Y.)115, 782–785 (1964)Google Scholar
  32. Van De Velde, R. L., Friedman, N. B.: Thymic myoid cells and myasthenia gravis. Amer. J. Path.59, 347–368 (1970)Google Scholar
  33. Weir, D. M.: Immunoferritin technique for the identification of antigen by electron microscopy in experimental immunology. Oxford-Edinbourgh: Blackwell Sci. Publ. 1967Google Scholar

Copyright information

© Springer-Verlag 1976

Authors and Affiliations

  • A. Korényi-Both
    • 1
    • 2
    • 3
  • Gabriella Kelemen
    • 1
    • 2
  1. 1.1st Institute of PathologySemmelweis Medical UniversityBudapestHungary
  2. 2.Biochemical Group of Eötvös Loránd UniversityBudapestHungary
  3. 3.Department of PathologyThe Genesee HospitalRochesterNew YorkUSA

Personalised recommendations